References
- Horowitz A, Stegmann KA, Riley EM. Activation of natural killer cells during microbial infections. Front Immunol. 2011;2:88. doi:https://doi.org/10.3389/fimmu.2011.00088
- Foley B, Felices M, Cichocki F, Cooley S, Verneris MR, Miller JS. The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT). Immunol Rev. 2014;258(1):45–63. doi:https://doi.org/10.1111/imr.12157
- Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, Yokoyama WM, Ugolini S. Innate or adaptive immunity? The example of natural killer cells. Science. 2011;331(6013):44–49. doi:https://doi.org/10.1126/science.1198687
- Cooper MA, Fehniger TA, Turner SC, Chen KS, Ghaheri BA, Ghayur T, Carson WE, Caligiuri MA. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood. 2001;97(10):3146–3151.
- Vivier E, Nunès JA, Vély F. Natural killer cell signaling pathways. Science. 2004;306(5701):1517–1519. doi:https://doi.org/10.1126/science.1103478
- Schmiedel D, Mandelboim O. NKG2D ligands-critical targets for cancer immune escape and therapy. Front Immunol. 2018;9:2040. doi:https://doi.org/10.3389/fimmu.2018.02040
- López-Soto A, Huergo-Zapico L, Acebes-Huerta A, Villa-Alvarez M, Gonzalez S. NKG2D signaling in cancer immunosurveillance. Int J Cancer. 2015;136(8):1741–1750. doi:https://doi.org/10.1002/ijc.28775
- Bugide S, Janostiak R, Wajapeyee N. Epigenetic mechanisms dictating eradication of cancer by natural killer cells. Trends Cancer. 2018;4(8):553–566. doi:https://doi.org/10.1016/j.trecan.2018.06.004
- Molinero LL, Fuertes MB, Girart MV, Fainboim L, Rabinovich GA, Costas MA, Zwirner NW. NF-kappa B regulates expression of the MHC class I-related chain A gene in activated T lymphocytes. J Immunol. 2004;173(9):5583–5590.
- Ogasawara K, Benjamin J, Takaki R, Phillips JH, Lanier KK. Function of NKG2D in natural killer cell–mediated rejection of mouse bone marrow grafts. Nat Immunol. 2005;6(9):938–945.
- Champsaur M, Lanier LL. Effect of NKG2D ligand expression on host immune responses. Immunol Rev. 2010;235(1):267–285. doi:https://doi.org/10.1111/j.0105-2896.2010.00893.x
- Baragaño Raneros A, Martín-Palanco V, Fernandez AF, Rodriguez RM, Fraga MF, Lopez-Larrea C, Suarez-Alvarez B. Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia. Genes Immun. 2015;16(1):71–82. doi:https://doi.org/10.1038/gene.2014.58
- Bar-El Dadon S, Reifen R. Vitamin A and the epigenome. Crit Rev Food Sci Nutr. 2017;57(11):2404–2411. doi:https://doi.org/10.1080/10408398.2015.1060940
- Su LJ, Mahabir S, Ellison GL, McGuinn LA, Reid BC. Epigenetic contributions to the relationship between cancer and dietary intake of nutrients, bioactive food components, and environmental toxicants. Front Genet. 2011;2:91. doi:https://doi.org/10.3389/fgene.2011.00091
- Gillberg L, Ørskov AD, Liu M, Harsløf LBS, Jones PA, Grønbaek K. Vitamin C - A new player in regulation of the cancer epigenome. Semin Cancer Biol. 2018;51:59–67. doi:https://doi.org/10.1016/j.semcancer.2017.11.001
- Zappe K, Pointner A, Switzeny OJ, Magnet U, Tomeva E, Heller J, Mare G, Wagner K-H, Knasmueller S, Haslberger AG. Counteraction of oxidative stress by vitamin E affects epigenetic regulation by increasing global methylation and gene expression of MLH1 and DNMT1 dose dependently in caco-2 cells. Oxid Med Cell Longev. 2018;2018:3734250. doi:https://doi.org/10.1155/2018/3734250
- Camarena V, Wang G. The epigenetic role of vitamin C in health and disease. Cell Mol Life Sci. 2016;73(8):1645–1658. doi:https://doi.org/10.1007/s00018-016-2145-x
- Wahid B, Ali A, Rafique S, Idrees M. New insights into the epigenetics of hepatocellular carcinoma. Biomed Res Int. 2017;2017:1609575. doi:https://doi.org/10.1155/2017/1609575
- Chaves GV, Peres WAF, Gonçalves JC, Ramalho A. Vitamin A and retinol-binding protein deficiency among chronic liver disease patients. Nutrition. 2015;31(5):664–668. doi:https://doi.org/10.1016/j.nut.2014.10.016
- Lan Q-Y, Zhang Y-J, Liao G-C, Zhou R-F, Zhou Z-G, Chen Y-M, Zhu H-L. The association between dietary vitamin A and carotenes and the risk of primary liver cancer: a case-control study. Nutrients. 2016;8(10):624. doi:https://doi.org/10.3390/nu8100
- Lv H, Wang C, Fang T. Vitamin C preferentially kills cancer stem cells in hepatocellular carcinoma via SVCT-2. npj Precis Oncol. 2018;2(1):1. doi:https://doi.org/10.1038/s41698-017-0044-8
- Chen Q, Espey MG, Sun AY, Pooput C, Kirk KL, Krishna MC, Khosh DB, Drisko J, Levine M. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci USA. 2008;105(32):11105–11109. doi:https://doi.org/10.1073/pnas.0804226105
- Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer. Proc Natl Acad Sci USA. 1978;75(9):4538–4542.
- Zhang W, Shu X-O, Li H, Yang G, Cai H, Ji B-T, Gao J, Gao Y-T, Zheng W, Xiang Y-B, et al. Vitamin intake and liver cancer risk: a report from two cohort studies in China. J Natl Cancer Inst. 2012;104(15):1173–1181. doi:https://doi.org/10.1093/jnci/djs277
- Bugide S, Green MR, Wajapeyee N. Inhibition of Enhancer of zeste homolog 2 (EZH2) induces natural killer cell-mediated eradication of hepatocellular carcinoma cells. Proc Natl Acad Sci USA. 2018;115(15):E3509–E3518. doi:https://doi.org/10.1073/pnas.1802691115
- Ghadially H, Brown L, Lloyd C, Lewis L, Lewis A, Dillon J, Sainson R, Jovanovic J, Tigue NJ, Bannister D, et al. MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue. Br J Cancer. 2017;116(9):1208–1217. doi:https://doi.org/10.1038/bjc.2017.79
- Watson NFS, Spendlove I, Madjd Z, McGilvray R, Green AR, Ellis IO, Scholefield JH, Durrant LG. Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patients. Int J Cancer. 2006;118(6):1445–1452. doi:https://doi.org/10.1002/ijc.21510
- Zhang W, Xu J. DNA methyltransferases and their roles in tumorigenesis. Biomark Res. 2017;5:1. doi:https://doi.org/10.1186/s40364-017-0081-z
- Fang Q-L, Yin Y-R, Xie C-R, Zhang S, Zhao W-X, Pan C, Wang X-M, Yin Z-Y. Mechanistic and biological significance of DNA methyltransferase 1 upregulated by growth factors in human hepatocellular carcinoma. Int J Oncol. 2015;46(2):782–790. doi:https://doi.org/10.3892/ijo.2014.2776
- Nishida N, Kudo M. Alteration of epigenetic profile in human hepatocellular carcinoma and its clinical implications. Liver Cancer. 2014;3(3–4):417–427. doi:https://doi.org/10.1159/000343860
- Mizuno S, Chijiwa T, Okamura T, Akashi K, Fukumaki Y, Niho Y, Sasaki H. Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood. 2001;97(5):1172–1179.
- Foran E, Garrity-Park MM, Mureau C, Newell J, Smyrk TC, Limburg PJ, Egan LJ. Upregulation of DNA methyltransferase-mediated gene silencing, anchorage-independent growth, and migration of colon cancer cells by interleukin-6. Mol Cancer Res. 2010;8(4):471–481. doi:https://doi.org/10.1158/1541-7786.MCR-09-0496
- Rhee I, Bachman KE, Park BH, Jair K-W, Yen R-WC, Schuebel KE, Cui H, Feinberg AP, Lengauer C, Kinzler KW, et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature. 2002;416(6880):552–556. doi:https://doi.org/10.1038/416552a
- Kohli RM, Zhang Y. TET enzymes, TDG and the dynamics of DNA demethylation. Nature. 2013;502(7472):472–479. doi:https://doi.org/10.1038/nature12750
- Lin G, Sun W, Yang Z, Guo J, Liu H, Liang J. Hypoxia induces the expression of TET enzymes in HepG2 cells. Oncol Lett. 2017;14(6):6457–6462. doi:https://doi.org/10.3892/ol.2017.7063
- Yang L, Yu S-J, Hong Q, Yang Y, Shao Z-M. Reduced expression of TET1, TET2, TET3 and TDG mRNAs are associated with poor prognosis of patients with early breast cancer. Guan X-Y, ed. PLoS One. 2015;10(7):e0133896. doi:https://doi.org/10.1371/journal.pone.0133896
- Yang H, Liu Y, Bai F, Zhang J-Y, Ma S-H, Liu J, Xu Z-D, Zhu H-G, Ling Z-Q, Ye D, et al. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene. 2013;32(5):663–669. doi:https://doi.org/10.1038/onc.2012.67
- Kai M, Niinuma T, Kitajima H, Yamamoto E, Harada T, Aoki H, Maruyama R, Toyota M, Sasaki Y, Sugai T, et al. TET1 depletion induces aberrant CpG methylation in colorectal cancer cells. PLoS One. 2016;11(12):e0168281. doi:https://doi.org/10.1371/journal.pone.0168281
- Sánchez-Abarca LI, Gutierrez-Cosio S, Santamaría C, Caballero-Velazquez T, Blanco B, Herrero-Sánchez C, García JL, Carrancio S, Hernández-Campo P, González FJ, et al. Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting. Blood. 2010;115(1):107–121. doi:https://doi.org/10.1182/blood-2009-03-210393
- Gailhouste L, Liew LC, Yasukawa K, Hatada I, Tanaka Y, Nakagama H, Ochiya T. Differentiation therapy by epigenetic reconditioning exerts antitumor effects on liver cancer cells. Mol Ther. 2018;26(7):1840–1854. doi:https://doi.org/10.1016/j.ymthe.2018.04.018
- Schneider-Stock R, Diab-Assef M, Rohrbeck A, Foltzer-Jourdainne C, Boltze C, Hartig R, Schönfeld P, Roessner A, Gali-Muhtasib H. 5-Aza-cytidine is a potent inhibitor of DNA methyltransferase 3a and induces apoptosis in HCT-116 colon cancer cells via Gadd45- and p53-dependent mechanisms. J Pharmacol Exp Ther. 2005;312(2):525–536. doi:https://doi.org/10.1124/jpet.104.074195
- Módis K, Coletta C, Asimakopoulou A, Szczesny B, Chao C, Papapetropoulos A, Hellmich MR, Szabo C. Effect of S-adenosyl-L-methionine (SAM), an allosteric activator of cystathionine-β-synthase (CBS) on colorectal cancer cell proliferation and bioenergetics in vitro. Nitric Oxide. 2014;41:146–156. doi:https://doi.org/10.1016/J.NIOX.2014.03.001
- Hussain Z, Khan MI, Shahid M, Almajhdi FN. S-adenosylmethionine, a methyl donor, up regulates tissue inhibitor of metalloproteinase-2 in colorectal cancer. Genet Mol Res. 2013;12(2):1106–1118. doi:https://doi.org/10.4238/2013.April.10.6
- Shrubsole MJ, Wagner C, Zhu X, Hou L, Loukachevitch LV, Ness RM, Zheng W. Associations between S-adenosylmethionine, S-adenosylhomocysteine, and colorectal adenoma risk are modified by sex. Am J Cancer Res. 2015;5(1):458–465.
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:https://doi.org/10.3322/caac.21492
- Nagai H, Kim YH. Cancer prevention from the perspective of global cancer burden patterns. J Thorac Dis. 2017;9(3):448–451. doi:https://doi.org/10.21037/jtd.2017.02.75
- Jasiulionis MG. Abnormal epigenetic regulation of immune system during aging. Front Immunol. 2018;9:197. doi:https://doi.org/10.3389/fimmu.2018.00197
- Zhang Q, Cao X. Epigenetic regulation of the innate immune response to infection. Nat Rev Immunol. 2019;19(7):417–432. doi:https://doi.org/10.1038/s41577-019-0151-6
- Anderson OS, Sant KE, Dolinoy DC. Nutrition and epigenetics: an interplay of dietary methyl donors, one-carbon metabolism and DNA methylation. J Nutr Biochem. 2012;23(8):853–859. doi:https://doi.org/10.1016/j.jnutbio.2012.03.003
- Blaschke K, Ebata KT, Karimi MM, Zepeda-Martínez JA, Goyal P, Mahapatra S, Tam A, Laird DJ, Hirst M, Rao A, et al. Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells. Nature. 2013;500(7461):222–226. doi:https://doi.org/10.1038/nature12362
- Melo F. d, Oliveira JS, Sartorelli VOB, Montor WR. Cancer chemoprevention: classic and epigenetic mechanisms inhibiting tumorigenesis. What have we learned so far? Front Oncol. 2018;8:644. doi:https://doi.org/10.3389/fonc.2018.00644